Adult Asthma Prevalence in the United States and New York State - 2013 BRFSS
Notes:
* U.S. Total excludes Puerto Rico, Guam and the Virgin Islands and designates an estimate for the 50 states and the District of Columbia combined.
** CI denotes confidence interval.
*** "Other" race does not include multiraces; "Other NH" race/ethnicity does not include multiraces Non-Hispanic.
Asthma Prevalence in the United States and New York State, Adults (18+ Yrs) - 2013 BRFSS
|
Sample Size |
Prevalence(%) |
95% CI** |
Estimated Number of People Affected |
US* Lifetime |
482,317 |
14.0 |
13.8-14.2 |
34,009,607 |
NYS Lifetime |
8,950 |
14.9 |
13.9-15.9 |
2,289,172 |
|
US* Current |
480,460 |
9.0 |
8.8-9.1 |
21,634,592 |
NYS Current |
8,911 |
9.7 |
8.9-10.6 |
1,486,160 |
Asthma Prevalence in the United States and New York State by Gender, Adults (18+ Yrs) - 2013 BRFSS
|
Gender |
Sample Size |
Prevalence(%) |
95% CI** |
Estimated Number of People Affected |
US* Lifetime |
Male |
197,569 |
11.7 |
11.4-12.0 |
13,800,508 |
Female |
284,748 |
16.2 |
15.9-16.5 |
20,209,099 |
NYS Lifetime |
Male |
3,709 |
12.3 |
10.8-13.7 |
900,425 |
Female |
5,241 |
17.3 |
15.9-18.7 |
1,388,747 |
|
US* Current |
Male |
196,859 |
6.3 |
6.1-6.5 |
7,376,443 |
Female |
283,601 |
11.5 |
11.2-11.7 |
14,258,149 |
NYS Current |
Male |
3,693 |
6.8 |
5.7-8.0 |
498,883 |
Female |
5,218 |
12.3 |
11.1-13.6 |
987,277 |
Asthma Prevalence in the United States and New York State by Age Group, Adults (18+ Yrs) - 2013 BRFSS
|
Age Group |
Sample Size |
Prevalence(%) |
95% CI** |
Estimated Number of People Affected |
US* Lifetime |
18-24 |
26,347 |
19.0 |
18.3-19.8 |
6,013,603 |
25-34 |
48,927 |
15.0 |
14.5-15.6 |
6,278,309 |
35-44 |
58,282 |
13.1 |
12.6-13.6 |
5,200,315 |
45-54 |
81,765 |
13.2 |
12.7-13.6 |
5,749,277 |
55-64 |
104,504 |
13.6 |
13.1-14.0 |
5,297,084 |
65+ |
157,922 |
11.7 |
11.4-12.0 |
5,258,538 |
NYS Lifetime |
18-24 |
631 |
19.3 |
15.2-23.3 |
374,547 |
25-34 |
1,162 |
18.0 |
15.3-20.6 |
493,012 |
35-44 |
1,171 |
13.9 |
11.2-16.6 |
341,390 |
45-54 |
1,561 |
13.8 |
11.7-15.9 |
383,003 |
55-64 |
1,726 |
13.8 |
11.8-15.8 |
330,034 |
65+ |
2,538 |
11.8 |
10.1-13.5 |
340,295 |
|
US* Current |
18-24 |
26,146 |
10.2 |
9.6-10.8 |
3,212,420 |
25-34 |
48,670 |
8.3 |
7.9-8.7 |
3,456,466 |
35-44 |
58,064 |
8.5 |
8.1-8.9 |
3,361,911 |
45-54 |
81,484 |
9.3 |
8.9-9.7 |
4,039,610 |
55-64 |
104,157 |
9.5 |
9.2-9.9 |
3,705,908 |
65+ |
157,389 |
8.3 |
8.0-8.6 |
3,711,195 |
NYS Current |
18-24 |
628 |
11.3 |
7.9-14.6 |
217,565 |
25-34 |
1,158 |
10.9 |
8.8-13.1 |
298,802 |
35-44 |
1,163 |
8.7 |
6.4-11.0 |
213,143 |
45-54 |
1,557 |
9.4 |
7.6-11.2 |
261,353 |
55-64 |
1,717 |
10.1 |
8.3-11.8 |
239,108 |
65+ |
2,527 |
8.3 |
6.9-9.8 |
239,012 |
Asthma Prevalence in the United States and New York State by Race, Adults (18+ Yrs) - 2013 BRFSS
|
Race |
Sample Size |
Prevalence(%) |
95% CI** |
Estimated Number of People Affected |
US* Lifetime |
White |
395,780 |
13.8 |
13.6-14.0 |
24,797,848 |
Black |
40,596 |
16.6 |
15.9-17.3 |
4,966,717 |
***Other |
27,897 |
11.8 |
11.0-12.6 |
2,622,422 |
Multi |
9,791 |
23.6 |
21.5-25.6 |
912,013 |
NYS Lifetime |
White |
6,561 |
15.1 |
13.9-16.3 |
1,522,298 |
Black |
1,172 |
18.2 |
15.0-21.4 |
447,703 |
***Other |
614 |
9.1 |
6.4 - 11.9 |
159,745 |
Multi |
109 |
24.8 |
14.0-35.6 |
45,766 |
|
US* Current |
White |
394,330 |
8.8 |
8.6-9.0 |
15,793,608 |
Black |
40,420 |
11.2 |
10.7-11.8 |
3,341,806 |
***Other |
27,776 |
6.7 |
6.1-7.2 |
1,480,925 |
Multi |
9,718 |
15.3 |
13.6-16.9 |
587,267 |
NYS Current |
White |
6,531 |
9.9 |
8.9-10.9 |
995,316 |
Black |
1,170 |
13.4 |
10.5-16.4 |
330,726 |
***Other |
611 |
3.9 |
2.2-5.5 |
67,451 |
Multi |
109 |
18.2 |
8.0-28.5 |
33,684 |
Asthma Prevalence in the United States and New York State by Race/Ethnicity, Adults (18+ Yrs) - 2013 BRFSS
|
Race/Ethnicity |
Sample Size |
Prevalence(%) |
95% CI** |
Estimated Number of People Affected |
US* Lifetime |
White NH |
375,071 |
14.1 |
13.9-14.3 |
21,753,903 |
Black NH |
39,031 |
16.6 |
15.9-17.3 |
4,637,706 |
***Other NH |
20,104 |
11.6 |
10.6-12.5 |
1,727,194 |
Multirace NH |
8,818 |
23.7 |
21.5-25.9 |
768,982 |
Hispanic |
30,905 |
12.0 |
11.3-12.6 |
4,417,656 |
NYS Lifetime |
White NH |
5,893 |
14.8 |
13.6-16.1 |
1,289,533 |
Black NH |
1,012 |
16.8 |
13.7-19.8 |
352,161 |
***Other NH |
462 |
7.1 |
4.4-9.7 |
95,430 |
Multirace NH |
86 |
25.2 |
12.6-37.8 |
37,798 |
Hispanic |
1,224 |
17.2 |
14.4-20.0 |
457,545 |
|
US* Current |
White NH |
373,702 |
9.1 |
8.9-9.3 |
14,036,654 |
Black NH |
38,859 |
11.2 |
10.7-11.8 |
3,121,610 |
***Other NH |
20,008 |
6.4 |
5.7-7.0 |
946,939 |
Multirace NH |
8,750 |
15.3 |
13.5-17.0 |
490,315 |
Hispanic |
30,793 |
7.0 |
6.5-7.5 |
2,564,539 |
NYS Current |
White NH |
5,868 |
9.9 |
8.8-11.0 |
857,266 |
Black NH |
1,010 |
12.3 |
9.6-15 |
257,363 |
***Other NH |
459 |
3.3 |
1.7-5.0 |
44,809 |
Multirace NH |
86 |
17.3 |
5.3-29.3 |
25,976 |
Hispanic |
1,219 |
9.9 |
7.6-12.2 |
262,498 |
Asthma Prevalence in the United States and New York State by Education, Adults (18+ Yrs) - 2013 BRFSS
|
Education |
Sample Size |
Prevalence(%) |
95% CI** |
Estimated Number of People Affected |
US* Lifetime |
HS Nongrad |
40,313 |
15.2 |
14.5-15.8 |
5,494,442 |
HS Grad |
140,338 |
13.7 |
13.4-14.1 |
9,448,636 |
Some Coll |
132,010 |
15.1 |
14.7-15.5 |
11,248,100 |
Coll Grad |
167,446 |
12.5 |
12.2-12.8 |
7,686,476 |
NYS Lifetime |
HS Nongrad |
887 |
18.8 |
15.2-22.3 |
447,156 |
HS Grad |
2,117 |
15.2 |
13.2-17.2 |
630,720 |
Some Coll |
2,127 |
15.2 |
13.3-17.0 |
627,973 |
Coll Grad |
3,758 |
12.5 |
11.2-13.9 |
573,824 |
|
US* Current |
HS Nongrad |
40,113 |
10.7 |
10.1-11.2 |
3,840,105 |
HS Grad |
139,799 |
8.8 |
8.5-9.1 |
6,038,225 |
Some Coll |
131,437 |
9.5 |
9.2-9.8 |
7,060,516 |
Coll Grad |
166,907 |
7.5 |
7.3-7.7 |
4,607,859 |
NYS Current |
HS Nongrad |
880 |
14.0 |
10.6-17.3 |
331,282 |
HS Grad |
2,106 |
9.4 |
7.9 - 11.0 |
388,338 |
Some Coll |
2,119 |
9.8 |
8.3-11.3 |
405,179 |
Coll Grad |
3,746 |
7.8 |
6.7-8.9 |
355,064 |
Asthma Prevalence in the United States and New York State by Income, Adults (18+ Yrs) - 2013 BRFSS
|
Income |
Sample Size |
Prevalence(%) |
95% CI** |
Estimated Number of People Affected |
US* Lifetime |
$0-$14,999 |
49,237 |
19.9 |
19.1-20.6 |
5,383,217 |
$15,000-$24,999 |
74,671 |
15.4 |
14.9-15.9 |
5,785,743 |
$25,000-$49,999 |
108,691 |
12.8 |
12.4-13.2 |
6,653,066 |
$50,000-$74,999 |
64,718 |
12.5 |
11.9-13.0 |
3,831,384 |
$75,000+ |
115,357 |
12.0 |
11.6-12.4 |
7,251,197 |
NYS Lifetime |
$0-$14,999 |
1,017 |
20.4 |
16.7-24.2 |
375,389 |
$15,000-$24,999 |
1,339 |
17.1 |
14.3-19.8 |
400,126 |
$25,000-$49,999 |
1,796 |
11.4 |
9.7-13.2 |
360,619 |
$50,000-$74,999 |
1,014 |
14.7 |
11.8-17.6 |
242,529 |
$75,000+ |
2,492 |
13.4 |
11.7-15.2 |
546,490 |
|
US* Current |
$0-$14,999 |
48,964 |
14.5 |
13.9-15.2 |
3,908,552 |
$15,000-$24,999 |
74,339 |
10.0 |
9.6-10.4 |
3,743,136 |
$25,000-$49,999 |
108,317 |
7.9 |
7.6-8.2 |
4,113,221 |
$50,000-$74,999 |
64,531 |
7.7 |
7.3-8.1 |
2,358,816 |
$75,000+ |
115,047 |
7.2 |
6.9-7.5 |
4,317,869 |
NYS Current |
$0-$14,999 |
1,011 |
15.8 |
12.3-19.4 |
289,235 |
$15,000-$24,999 |
1,332 |
11.4 |
9.2-13.7 |
266,125 |
$25,000-$49,999 |
1,791 |
8.0 |
6.5-9.5 |
252,481 |
$50,000-$74,999 |
1,009 |
7.7 |
5.7-9.6 |
125,620 |
$75,000+ |
2,482 |
7.4 |
6.1-8.7 |
301,407 |
Note: If values for the 95% confidence interval are not provided, the normal approximation to the binomial distribution does not apply due to small sample size.